How Trees May Support Immune Function
Spending time among trees can feel calming. However, phytoncides and immune function may have a connection that goes beyond relaxation and mental health.
Trees and other plants release natural airborne compounds called phytoncides. Researchers have been studying whether breathing these compounds during forest exposure can influence the immune system. A 2024 systematic review and meta-analysis provides intriguing human evidence that they may.
What the Research Found
Researchers reviewed eight human studies and included six studies, involving 79 participants, in their analysis of natural killer cell activity.
Natural killer, or NK, cells are part of the body’s early immune defense. They recognize and help eliminate certain infected or abnormal cells.
Across the studies, phytoncide exposure was associated with a significant increase in NK-cell activation. Several studies also reported increases in immune molecules such as perforin, granzymes, and granulysin, which NK cells use as part of their cytotoxic response.
Importantly, this does not prove that spending time in a forest prevents infections, cancer, or other diseases. The researchers rated the overall certainty of evidence as low, largely because the studies were small and most did not isolate phytoncides from other parts of forest exposure.
Phytoncides and Immune Function: Why It Matters
The findings raise an important possibility.
Nature may influence immunity through more than one route.
A calm natural environment may reduce stress and autonomic demand. In turn, that regulatory shift may influence downstream immune behavior. However, phytoncides suggest an additional pathway:
forest-derived compounds → altered immune-cell activity
In fact, the review also describes evidence connecting phytoncide exposure with autonomic changes. Therefore, the biology may involve interaction between the environment, nervous system, endocrine signaling, and immune system rather than one isolated pathway.
How This Fits Into Healing in Order
Within EFP, nature exposure belongs primarily in Phase 1, where reducing unnecessary regulatory demand helps establish a more stable foundation.
This research adds legitimate secondary Phase 2 relevance.
The distinction matters. Nature does not suddenly become an immune treatment. Instead, the research strengthens the idea that an intervention introduced for regulatory support may also influence downstream immune physiology.
That is consistent with a central principle of Healing in Order: the body’s systems do not recover in isolation.
What This Research Changes
Existing EFP Concept: Strengthened
The research does not create a new EFP concept or change the phase sequence.
Instead, it strengthens the biological explanation for why forest environments may influence immune function. Phytoncides are no longer merely a speculative explanation. Human studies now provide direct evidence of changes in NK-cell activity following phytoncide exposure, although larger and better-controlled trials are still needed.
Practical Meaning for the Reader
Nature may provide more than a pleasant setting.
Trees can change the sensory environment around us, while compounds released by those trees may also interact with our biology.
The evidence is still developing. Yet it reinforces an important idea: when we change the environment surrounding the body, we may change more than how the body feels. We may also change some of the biological signals it receives.
Final Perspective
Healing depends on communication between systems.
The nervous system influences immune behavior. The immune system influences how we feel and recover. Now research suggests that even compounds released by the natural environment may participate in that conversation.
The forest is not medicine in the conventional sense.
But it may be more biologically active than it appears.
Research Source
Lew T, Fleming KJ, et al. Phytoncides and immunity from forest to facility: A systematic review and meta-analysis. Pharmacological Research – Natural Products. 2024;4:100061. DOI: 10.1016/j.prenap.2024.100061.




Leave a Comment